RxDoctor Payments Data

Pierre Tibi, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Prescott, AZNPI 1811926660

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.2%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.1%. Reporting peaked in 2024 at $40,907 and has fallen 76.9% since, to $9,439 in 2025.

$76,950in general payments, 2019–2025

Across 128 payments — averaging $601.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$15K
  • Baxter Healthcare$12K
  • Pharmacosmos Therapeutics Inc.$12K
  • Hemosonics LLC$11K
  • American Regent$10K
  • Grifols Shared Services North America, Inc.$9K
  • plus $8K from 23 others
$30,500in research payments, 2019–2025

Across 3 payments — averaging $10,167 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Hemosonics LLC$31K

What the payments were for

  • Consulting fees$33,99944%
  • Speaking & faculty fees$11,82115%
  • Travel & lodging$21,45828%
  • Food & beverage$6,3288%
  • Education$3,3454%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,950 in reported general payments places this provider in the 85th percentile of 100 thoracic surgery (cardiothoracic vascular surgery) providers in Arizona.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Arizona

Medicare billing

Part B allowed, 2024
$70,373
Medicare patients
46
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin22$132

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Prescott

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →